The onset of nonmotor symptoms in parkinson's disease (the onset pd study)

Movement Disorders

Volumn 30, Issue 2, 2015, Pages 229-237

  Pont Sunyer, Claustre ^a   Hotter, Anna ^b,c   Gaig, Carles ^a   Seppi, Klaus ^b,c   Compta, Yaroslau ^a   Katzenschlager, Regina ^c,d   Mas, Natalia ^a   Hofeneder, Dominik ^c,e   Brücke, Thomas ^c,e   Bayés, Angels ^f   Wenzel, Karoline ^c,g   Infante, Jon ^h   Zach, Heidemarie ^c,i   Pirker, Walter ^c,i   Posada, Ignacio J ^j   Álvarez, Ramiro ^k   Ispierto, Lourdes ^k   De Fàbregues, Oriol ^l   Callén, Antoni ^l   Palasí, Antoni ^l   Aguilar, Miquel ^m   Martí, Maria José ^a   Valldeoriola, Francesc ^a   Salamero, Manel ^a   Poewe, Werner ^b,c   Tolosa, Eduardo ^a   more..

^a UNIVERSITY OF BARCELONA   (Spain)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c Austrian PD Study Group   (Austria)

^d Wiener Krankenanstaltenverbund   (Austria)

^e WILHELMINEN HOSPITAL   (Austria)

^f Unidad de Parkinson Teknon   (Spain)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

^h HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

^j HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^k HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^l HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^m HOSPITAL MÚTUA DE TERRASSA   (Spain)

more..

Author keywords

Nonmotor symptoms; Parkinson's disease; Premotor phase

Indexed keywords

ABNORMAL DREAMING; ADULT; AGED; AGEUSIA; ANHEDONIA; ANOSMIA; APATHY; ARTICLE; ATTENTION DISTURBANCE; COGNITIVE DEFECT; CONSTIPATION; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DISEASE SEVERITY; EPIGASTRIC FULLNESS; FATIGUE; FEMALE; HUMAN; HYPERHIDROSIS; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MOOD DISORDER; MOTOR DYSFUNCTION; PAIN; PARASOMNIA; PARKINSON DISEASE; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SYMPTOM; COMPLICATION; DIFFERENTIAL DIAGNOSIS; MENTAL DISORDERS; MIDDLE AGED; OLFACTION DISORDERS; ONSET AGE; PATHOPHYSIOLOGY; QUESTIONNAIRE; RISK; VERY ELDERLY;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CONSTIPATION; DIAGNOSIS, DIFFERENTIAL; FATIGUE; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; OLFACTION DISORDERS; PARKINSON DISEASE; QUESTIONNAIRES; RISK;

EID: 84922268526     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26077     Document Type: Article

References (50)

1. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001;57:456-462.
2. Iranzo A, Molinuevo JL, Santamaria J, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006;5: 572-577.
3. Ross GW, Petrovitch H, Abbott RD, et al. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008;63:167-173.
4. Shiba M, Bower JH, Maraganore DM, et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 2000;15:669-677.
5. Becker G, Muller A, Braune S, et al. Early diagnosis of Parkinson's disease. J Neurol 2002;249 Suppl 3:III/40-III/48.
6. Tolosa E, Compta Y, Gaig C. The premotor phase of Parkinson's disease. Parkinsonism Relat Disord 2007;13(Suppl):S2-S7.
7. Gonera EG, van't Hof M, Berger HJ, van Weel C, Horstink MW. Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord 1997;12:871-876.
8. Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006;66:845-851.
9. Reijnders JS, Ehrt U, Lousberg R, Aarsland D, Leentjens AF. The association between motor subtypes and psychopathology in Parkinson's disease. Parkinsonism Relat Disord 2009;15:379-382.
10. Stern MB, Doty RL, Dotti M, et al. Olfactory function in Parkinson's disease subtypes. Neurology 1994;44:266-268.
11. Kumru H, Santamaria J, Tolosa E, Iranzo A. Relation between subtype of Parkinson's disease and REM sleep behavior disorder. Sleep Med 2007;8:779-783.
12. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
13. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 2003;18:738-750.
14. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23:2129-2170.
15. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
16. Schwab JF, England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Billingham FH, Donaldson MC eds. Third Symposium on Parkinson's Disease. Edinburgh, UK: E & S Livingstone; 1969:152-157.
17. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997;22:39-52.
18. Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 1984;32:489-502.
19. Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007;22:1901-1911.
20. Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 2004;19:1306-1312.
21. Doty RL, ed. The Smell Identification Test Administration Manual, 3rd ed. Haddon Heights, NJ: Sensonics; 1995.
22. MacQueen JB. Some methods for classification and analysis of multivariate observations. In: Neyman J, ed. Proceedings of 5th Berkeley Symposium on Mathematical Statistics and Probability. Berkeley, CA: University of California Press; 1967:281-297.
23. Ward JH. Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963:236-244.
24. Buskova J, Klempir J, Majerova V, et al. Sleep disturbances in untreated Parkinson's disease. J Neurol 2011;258:2254-2259.
25. Gaenslen A, Swid I, Liepelt-Scarfone I, Godau J, Berg D. The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease. Mov Disord 2011;26:653-658.
26. Gao X, Chen H, Schwarzschild MA, et al. Erectile function and risk of Parkinson's disease. Am J Epidemiol 2007;166:1446-1450.
27. Khoo TK, Yarnall AJ, Duncan GW, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 2013;80:276-281.
28. Muller B, Larsen JP, Wentzel-Larsen T, Skeie GO, Tysnes OB. Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: frequent but mild. Mov Disord 2011;26:65-72.
29. Erro R, Picillo M, Vitale C, et al. Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. J Neurol Neurosurg Psychiatry 2013;84:14-17.
30. Kim HJ, Park SY, Cho YJ, et al. Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. J Neurol Sci 2009;287:200-204.
31. Martinez-Martin P, Chaudhuri KR, Rojo-Abuin JM, et al. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J Neurol 2013 Apr 22. doi: 10.1111/ene.12165. [Epub ahead of print].
32. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006;21:916-923.
33. Duncan GW, Khoo TK, Yarnall AJ, et al. Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms. Mov Disord 2014;29:195-202.
34. Mollenhauer B, Trautmann E, Sixel-Doring F, et al. Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort. Neurology 2013;81:1226-1234.
35. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003;60: 387-392.
36. Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A. Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology 2009;73:206-212.
37. Baba T, Kikuchi A, Hirayama K, et al. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. Brain 2012;135:161-169.
38. Domellof ME, Elgh E, Forsgren L. The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease. Mov Disord 2011;26:2183-2189.
39. Tolosa E, Poewe W. Premotor Parkinson disease. Neurology 2009; 72(7 Suppl):S1.
40. O'Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ. Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study. Mov Disord 2008;23:101-106.
41. Abbott RD, Ross GW, White LR, et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 2005;65:1442-1446.
42. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
43. Romenets SR, Gagnon JF, Latreille V, et al. Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease. Mov Disord 2012;27:996-1003.
44. Factor SA, Steenland NK, Higgins DS, et al. Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis. J Neurol Neurosurg Psychiatry 2011;82:564-568.
45. van Rooden SM, Colas F, Martinez-Martin P, et al. Clinical subtypes of Parkinson's disease. Mov Disord 2011;26:51-58.
46. van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, Marinus J. The identification of Parkinson's disease subtypes using cluster analysis: a systematic review. Mov Disord 2010;25:969-978.
47. Erro R, Vitale C, Amboni M, et al. The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. PLoS One 2013;8:e70244.
48. Berg D, Godau J, Seppi K, et al. The PRIPS study: screening battery for subjects at risk for Parkinson's disease. Eur J Neurol 2013; 20:102-108.
49. Siderowf A, Jennings D, Eberly S, et al. Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Mov Disord 2012;27:406-412.
50. Stern MB, Siderowf A. Parkinson's at risk syndrome: can Parkinson's disease be predicted? Mov Disord 2010;25(Suppl 1):S89-S93.